Published in J Clin Endocrinol Metab on August 11, 2010
Delivery type not associated with global methylation at birth. Clin Epigenetics (2012) 0.90
Copeptin concentration in cord blood in infants with early-onset sepsis, chorioamnionitis and perinatal asphyxia. BMC Pediatr (2011) 0.82
Arginine Vasopressin and Copeptin in Perinatology. Front Pediatr (2016) 0.81
Who plays the strings in newborn analgesia at birth, vasopressin or oxytocin? Front Neurosci (2012) 0.79
Copeptin levels are associated with organ dysfunction and death in the intensive care unit after out-of-hospital cardiac arrest. Crit Care (2015) 0.77
Arginine-vasopressin marker copeptin is a sensitive plasma surrogate of hypoxic exposure. Hypoxia (Auckl) (2014) 0.75
Decreased neonatal pain response after vaginal-operative delivery with Kiwi OmniCup versus metal ventouse. BMC Pregnancy Childbirth (2017) 0.75
Primary palliative care in the delivery room: patients' and medical personnel's perspectives. J Perinatol (2015) 0.75
Serum copeptin and neuron specific enolase are markers of neonatal distress and long-term neurodevelopmental outcome. PLoS One (2017) 0.75
Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. JAMA (2009) 5.52
Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure. Nat Genet (2009) 3.81
A randomized trial evaluating a predominantly fetal growth-based strategy to guide management of gestational diabetes in Caucasian women. Diabetes Care (2004) 2.94
Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. J Am Coll Cardiol (2010) 2.25
Oral ibuprofen versus intravenous ibuprofen or intravenous indomethacin for the treatment of patent ductus arteriosus in preterm infants: a systematic review and meta-analysis. Neonatology (2012) 2.10
Pro-atrial natriuretic peptide and pro-vasopressin to predict severity and prognosis in community-acquired pneumonia: results from the German competence network CAPNETZ. Intensive Care Med (2007) 2.06
The special role of ultrasound for screening, staging and surveillance of malignant ovarian tumors: distinction from other methods of diagnostic imaging. Arch Gynecol Obstet (2013) 2.03
Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen. N Engl J Med (2008) 2.01
Diagnostic approach to microcephaly in childhood: a two-center study and review of the literature. Dev Med Child Neurol (2014) 1.95
The influence of corticosteroids on the release of novel biomarkers in human endotoxemia. Intensive Care Med (2007) 1.92
Thyrotropin receptor autoantibodies are independent risk factors for Graves' ophthalmopathy and help to predict severity and outcome of the disease. J Clin Endocrinol Metab (2006) 1.92
The vasopressin and copeptin response to infection, severe sepsis, and septic shock. Crit Care Med (2009) 1.85
Syncytin, a novel human endogenous retroviral gene in human placenta: evidence for its dysregulation in preeclampsia and HELLP syndrome. Am J Obstet Gynecol (2002) 1.84
Assessment of conventional cardiovascular risk factors and multiple biomarkers for the prediction of incident heart failure and atrial fibrillation. J Am Coll Cardiol (2010) 1.77
Copeptin: a novel, independent prognostic marker in patients with ischemic stroke. Ann Neurol (2009) 1.73
Incremental value of copeptin for rapid rule out of acute myocardial infarction. J Am Coll Cardiol (2009) 1.71
Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397]. Crit Care (2006) 1.70
Copeptin, C-reactive protein, and procalcitonin as prognostic biomarkers in acute exacerbation of COPD. Chest (2007) 1.64
Oxygen-regulated expression of the RNA-binding proteins RBM3 and CIRP by a HIF-1-independent mechanism. J Cell Sci (2004) 1.62
C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study. Circulation (2007) 1.59
Online support for parents of preterm infants: a qualitative and content analysis of Facebook 'preemie' groups. Arch Dis Child Fetal Neonatal Ed (2013) 1.58
Copeptin, a stable peptide derived from the vasopressin precursor, is elevated in serum of sepsis patients. Peptides (2005) 1.57
NEK1 mutations cause short-rib polydactyly syndrome type majewski. Am J Hum Genet (2011) 1.56
Hypoxia upregulates the histone demethylase JMJD1A via HIF-1. Biochem Biophys Res Commun (2008) 1.55
Midregional pro-atrial natriuretic peptide and outcome in patients with acute ischemic stroke. J Am Coll Cardiol (2010) 1.55
Birth weight and parental BMI predict overweight in children from mothers with gestational diabetes. Diabetes Care (2005) 1.54
Fatal congenital heart glycogenosis caused by a recurrent activating R531Q mutation in the gamma 2-subunit of AMP-activated protein kinase (PRKAG2), not by phosphorylase kinase deficiency. Am J Hum Genet (2005) 1.51
Impact of sepsis on neurodevelopmental outcome in a Swiss National Cohort of extremely premature infants. Pediatrics (2011) 1.51
The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients. Am J Obstet Gynecol (2011) 1.50
Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study. Crit Care (2005) 1.49
Special considerations for stage IV melanoma during pregnancy. Arch Dermatol (2005) 1.46
A novel method for the in vivo isolation of circulating tumor cells from peripheral blood of cancer patients using a functionalized and structured medical wire. Int J Oncol (2012) 1.44
Potential markers of preeclampsia--a review. Reprod Biol Endocrinol (2009) 1.44
Plasma copeptin and the risk of diabetes mellitus. Circulation (2010) 1.44
Tracheal tube airleak in clinical practice and impact on tidal volume measurement in ventilated neonates. Pediatr Crit Care Med (2011) 1.41
Changes in plasma copeptin, the c-terminal portion of arginine vasopressin during water deprivation and excess in healthy subjects. J Clin Endocrinol Metab (2007) 1.39
Association of maternal and/or fetal factor V Leiden and G20210A prothrombin mutation with HELLP syndrome and intrauterine growth restriction. Clin Sci (Lond) (2003) 1.39
Hematologic effects of maternal antiretroviral therapy and transmission prophylaxis in HIV-1-exposed uninfected newborn infants. J Acquir Immune Defic Syndr (2007) 1.34
Identification of an Adrenomedullin precursor fragment in plasma of sepsis patients. Peptides (2004) 1.32
Copeptin, a novel prognostic biomarker in ventilator-associated pneumonia. Crit Care (2008) 1.32
Low plasma level of atrial natriuretic peptide predicts development of diabetes: the prospective Malmo Diet and Cancer study. J Clin Endocrinol Metab (2011) 1.31
Immunoluminometric assay for measurement of the C-terminal endothelin-1 precursor fragment in human plasma. Clin Chem (2006) 1.30
NMDA antagonist inhibits the extracellular signal-regulated kinase pathway and suppresses cancer growth. Proc Natl Acad Sci U S A (2005) 1.30
MRSA transmission on a neonatal intensive care unit: epidemiological and genome-based phylogenetic analyses. PLoS One (2013) 1.29
Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease. J Am Coll Cardiol (2008) 1.27
Quantitative proteomics analysis of maternal plasma in Down syndrome pregnancies using isobaric tagging reagent (iTRAQ). J Biomed Biotechnol (2009) 1.25
IL-18: a key player in neuroinflammation and neurodegeneration? Trends Neurosci (2005) 1.25
New assay for the measurement of selenoprotein P as a sepsis biomarker from serum. J Trace Elem Med Biol (2008) 1.24
Erythropoietin protects the developing brain against N-methyl-D-aspartate receptor antagonist neurotoxicity. Neurobiol Dis (2004) 1.23
Five new TTF1/NKX2.1 mutations in brain-lung-thyroid syndrome: rescue by PAX8 synergism in one case. Hum Mol Genet (2009) 1.23
An approach to using recombinant erythropoietin for neuroprotection in very preterm infants. Pediatrics (2008) 1.22
New gestational phase-specific cutoff values for the use of the soluble fms-like tyrosine kinase-1/placental growth factor ratio as a diagnostic test for preeclampsia. Hypertension (2013) 1.20
Therapeutic hypothermia in neonates. Review of current clinical data, ILCOR recommendations and suggestions for implementation in neonatal intensive care units. Resuscitation (2008) 1.20
Copeptin and arginine vasopressin concentrations in critically ill patients. J Clin Endocrinol Metab (2006) 1.19
Population based trends in mortality, morbidity and treatment for very preterm- and very low birth weight infants over 12 years. BMC Pediatr (2012) 1.19
Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure. J Am Coll Cardiol (2007) 1.18
Oxygen causes cell death in the developing brain. Neurobiol Dis (2004) 1.18
Anterior and posterior pituitary function testing with simultaneous insulin tolerance test and a novel copeptin assay. J Clin Endocrinol Metab (2007) 1.18
Prognostic value of copeptin: one-year outcome in patients with acute stroke. Stroke (2010) 1.17
The role of copeptin as a diagnostic and prognostic biomarker for risk stratification in the emergency department. BMC Med (2012) 1.17
Prohormones for prediction of adverse medical outcome in community-acquired pneumonia and lower respiratory tract infections. Crit Care (2010) 1.17
The RNA-binding protein RBM3 is required for cell proliferation and protects against serum deprivation-induced cell death. Pediatr Res (2010) 1.14
Copeptin helps in the early detection of patients with acute myocardial infarction: primary results of the CHOPIN trial (Copeptin Helps in the early detection Of Patients with acute myocardial INfarction). J Am Coll Cardiol (2013) 1.13
Copeptin in the differential diagnosis of hyponatremia. J Clin Endocrinol Metab (2008) 1.13
The RNA-binding protein RBM3 is involved in hypothermia induced neuroprotection. Neurobiol Dis (2011) 1.11
Copeptin is associated with mortality and outcome in patients with acute intracerebral hemorrhage. BMC Neurol (2010) 1.11
Plasma carboxy-terminal provasopressin (copeptin): a novel marker of insulin resistance and metabolic syndrome. J Clin Endocrinol Metab (2009) 1.11
Neurodegeneration in newborn rats following propofol and sevoflurane anesthesia. Neurotox Res (2009) 1.11
NKX2-1 mutations leading to surfactant protein promoter dysregulation cause interstitial lung disease in "Brain-Lung-Thyroid Syndrome". Hum Mutat (2010) 1.11
Long-term treatment with tetrahydrobiopterin increases phenylalanine tolerance in children with severe phenotype of phenylketonuria. Mol Genet Metab (2005) 1.10
Sirenomelia, the mermaid syndrome--detection in the first trimester. Prenat Diagn (2003) 1.08
Plasma N-terminal B-Type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: comparison with plasma midregional pro-atrial natriuretic peptide: the LAMP (Leicester Acute Myocardial Infarction Peptide) study. J Am Coll Cardiol (2008) 1.08
The relationship between adrenomedullin, metabolic factors, and vascular function in individuals with type 2 diabetes. Diabetes Care (2007) 1.07
Increased 90-day mortality in patients with acute heart failure with elevated copeptin: secondary results from the Biomarkers in Acute Heart Failure (BACH) study. Circ Heart Fail (2011) 1.05
Prognostic value of midregional pro-atrial natriuretic peptide in ventilator-associated pneumonia. Intensive Care Med (2008) 1.04
Avoiding endotracheal ventilation to prevent bronchopulmonary dysplasia: a meta-analysis. Pediatrics (2013) 1.04
Effects of moderate and deep hypothermia on RNA-binding proteins RBM3 and CIRP expressions in murine hippocampal brain slices. Brain Res (2013) 1.03
Mid-regional pro-adrenomedullin as a novel predictor of mortality in patients with chronic heart failure. Eur J Heart Fail (2010) 1.02
Delineation of the discontinuous-conformational epitope of a monoclonal antibody displaying full in vitro and in vivo thyrotropin activity. Mol Endocrinol (2004) 1.02
Patients with severe Graves' ophthalmopathy have a higher risk of relapsing hyperthyroidism and are unlikely to remain in remission. Clin Endocrinol (Oxf) (2007) 1.01
Copeptin, procalcitonin and routine inflammatory markers-predictors of infection after stroke. PLoS One (2012) 1.01
Midregion prohormone adrenomedullin and prognosis in patients presenting with acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. J Am Coll Cardiol (2011) 1.01
Positive correlation of cell-free DNA in plasma/serum in patients with malignant and benign breast disease. Anticancer Res (2008) 1.01
Hypothermia: an evolving treatment for neonatal hypoxic ischemic encephalopathy. Pediatrics (2008) 1.01
Prevention of hyperoxia-mediated pulmonary inflammation in neonatal rats by caffeine. Eur Respir J (2012) 1.01
Plasma pro-adrenomedullin but not plasma pro-endothelin predicts survival in exacerbations of COPD. Chest (2008) 1.00
Maturation-dependent oligodendrocyte apoptosis caused by hyperoxia. J Neurosci Res (2006) 1.00
Axillary cavernous lymphangioma in pregnancy and puerperium. Gynecol Obstet Invest (2005) 1.00
Correlation of plasma copeptin and vasopressin concentrations in hypo-, iso-, and hyperosmolar States. J Clin Endocrinol Metab (2011) 1.00
Hemodynamic response to visual stimulation in newborn infants using functional near-infrared spectroscopy. Hum Brain Mapp (2008) 1.00
C-terminal provasopressin (copeptin) is associated with left ventricular dysfunction, remodeling, and clinical heart failure in survivors of myocardial infarction. J Card Fail (2008) 1.00
Prognostic value of plasma midregional pro-adrenomedullin and C-terminal-pro-endothelin-1 in chronic heart failure outpatients. Eur J Heart Fail (2009) 0.99
Circulating precursor levels of endothelin-1 and adrenomedullin, two endothelium-derived, counteracting substances, in sepsis. Endothelium (2007) 0.99
Panhypopituitarism presenting as life-threatening heart failure caused by an inherited microdeletion in 1q25 including LHX4. Pediatrics (2012) 0.99
Plasma copeptin, a unifying factor behind the metabolic syndrome. J Clin Endocrinol Metab (2011) 0.98
Polymorphic length of FOXE1 alanine stretch: evidence for genetic susceptibility to thyroid dysgenesis. Hum Genet (2007) 0.98
Molecular mechanisms of thyroid dysgenesis. Horm Res (2004) 0.97
Identification of chronic heart failure patients with a high 12-month mortality risk using biomarkers including plasma C-terminal pro-endothelin-1. PLoS One (2011) 0.97